Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

10 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 6091 to 6100 of 10349

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

6091	A controlled multicentre study comparing early treatment with polytetrafluoroethylene (PTFE) covered stents (Viator) versus optimised medical treatment in patients with cirrhosis and a high risk variceal bleeding episode
	ISRCTN:	ISRCTN58150114
	Sponsor:	Individual Sponsor (Spain)
	Date assigned:	24 March 2006

6092	A randomized phase IV clinical trial comparing Nadolol and Isosorbide Mononitrate (ISMN) with the combination of Endoscopic Banding Ligation plus Nadolol and ISMN in the prevention of variceal rebleeding
	ISRCTN:	ISRCTN26221020
	Sponsor:	Individual Sponsor (Spain)
	Date assigned:	24 March 2006

6093	Pilot Phase III immunotherapy study in early breast cancer patients using oxidized mannan-MUC1
	ISRCTN:	ISRCTN71711835
	Sponsor:	Prolipsis Medical Center (Greece)
	Date assigned:	24 March 2006

6094	Influence of different types of dialysis membranes on parameters of chronic inflammation
	ISRCTN:	ISRCTN47228763
	Sponsor:	Gambro SAS (France)
	Date assigned:	24 March 2006

6095	Clinical assessment of a new catheter surface coating with antimicrobial properties: safety - handling - efficacy
	ISRCTN:	ISRCTN81821807
	Sponsor:	Gambro Corporate Research (Germany)
	Date assigned:	24 March 2006

6096	High cut-off Continuous venovenous haemodialysis (CVVHD) to improve haemodynamic stability and Organ function scores in patients treated for acute renal failure after Systemic inflammatory response Syndrome (SIRS)/septic shock
	ISRCTN:	ISRCTN77656437
	Sponsor:	Gambro Dialysatoren GmbH (Germany)
	Date assigned:	24 March 2006

6097	Which oxygen saturation level should we use for very premature infants? A randomised controlled trial
	ISRCTN:	ISRCTN00842661
	Sponsor:	University of Oxford (UK)
	Date assigned:	23 March 2006

6098	Steroid Avoidance in Leeds with Alemtuzumab or Mycophenolate Mofetil (MMF) Immunosuppression
	ISRCTN:	ISRCTN94424606
	Sponsor:	Leeds Teaching Hospitals NHS Trust (UK)
	Date assigned:	23 March 2006

6099	Influence of glucose degradation products on residual renal function in peritoneal dialysis (PD) patients
	ISRCTN:	ISRCTN71335154
	Sponsor:	Gambro Corporate Research (Germany)
	Date assigned:	23 March 2006

6100	Single-investigator, randomized, double-blind, placebo-controlled trial of the efficacy and safety of oral antibiotics versus placebo in recurrent seropositive and seronegative Lyme disease
	ISRCTN:	ISRCTN19325889
	Sponsor:	Lyme Disease Practice and Research (USA)
	Date assigned:	22 March 2006

RESULT PAGE

610


© 2012 ISRCTN unless otherwise stated.